Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Interferon production enhancer discovered by Japanese researchers

Sep. 6, 1996

New agents for use in transplantation

Aug. 30, 1996

Aviron's intranasal influenza vaccine begins phase III

Aug. 30, 1996

FDA approval requested for thymoglobin manufacturing process, facility

Aug. 30, 1996

STV: Possible antituberculosis and autoimmune disease therapy

Aug. 23, 1996

Immunomodulating peptides from BioChem Pharma

Aug. 23, 1996

Cel-Sci and U.S. Navy collaborate on malaria vaccine

Aug. 23, 1996

North American Vaccine/Abbott DTaP marketing agreement

Aug. 23, 1996

Acellular antiBortedella vaccine claimed by Institut Pasteur

Aug. 16, 1996

Oxygermylpropionic acid polymer reported by Sanwa Kagaku

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...